Arrow Therapeutics

About:

Arrow is a small pharmaceutical company strictly focussed on novel anti-infective discovery.

Website: http://www.arrowt.co.uk

Top Investors: Atlas Venture, Alta Partners, 3i Group, Gimv, TVM Capital

Description:

Arrow Therapeutics was founded in 1998 and is already making a significant contribution to anti-infective drug discovery. Microbial resistance to existing drugs is an ever increasing threat that is leading to serious unmet medical need and incurring a huge financial burden on society. Despite the huge challenges of this situation it also presents excellent opportunities to combine scientific research and business. As more and more big pharma groups concentrate their efforts on drug development, greater chances are open to smaller companies such as ours to show their excellence in research.

Total Funding Amount:

40M GBP

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

London, England, United Kingdom

Founded Date:

1998-01-01

Founders:

Ken Powell

Number of Employees:

101-250

Last Funding Date:

2003-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai